Peter, K <br/><br/>
Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine.  [electronic resource] 

 -  Circulation  Sep 2000 
 - 1490-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.102.13.1490  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Aged<br/>Antibodies, Monoclonal--blood<br/>Blood Platelets--drug effects<br/>Female<br/>Fibrinolytic Agents--blood<br/>Flow Cytometry<br/>Humans<br/>Immunoglobulin Fab Fragments--blood<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--blood<br/>Platelet Glycoprotein GPIIb-IIIa Complex--drug effects<br/>Recombinant Proteins--blood<br/>Ticlopidine--blood<br/>Time Factors<br/>Tissue Plasminogen Activator--blood